ArticleJAMA network open2022

Considering the Future of Pediatric Multiple Sclerosis Trials After the CONNECT Open-Label Randomized Trial.

Omar Abdel-Mannan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.